Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.
about
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesisThe stomach in health and diseaseEpidemiology of Barrett's Esophagus and Esophageal AdenocarcinomaGastric cancer: descriptive epidemiology, risk factors, screening, and preventionRecent developments in esophageal adenocarcinomaGastric cancer: prevention, screening and early diagnosisSystematic review: potential preventive effects of statins against oesophageal adenocarcinomaEpidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this diseaseCyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardScreening and treating Helicobacter pylori infection for gastric cancer prevention on the population level.Environmental risk factors for pancreatic cancer: an update.NSAIDs modulate clonal evolution in Barrett's esophagus.Nature meets nurture: molecular genetics of gastric cancer.Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysisFamily history and the risk of gastric cancer.Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study.At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.Decreased risk of squamous cell carcinoma of the head and neck in users of nonsteroidal anti-inflammatory drugsSex-specific exposure prevalence of established risk factors for oesophageal adenocarcinomaGastric cancer: an infectious diseasePlatelets and cancer: a casual or causal relationship: revisited.Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition.Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysisNSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical managementNonsteroidal anti-inflammatory drug and acetaminophen use and risk of adult myeloid leukemia.Helicobacter pylori Infection and Gastric Adenocarcinoma.American Gastroenterological Association technical review on the management of Barrett's esophagusIbuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms.Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity.Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies.The Effects of Anti-inflammatory Drug Treatment in Gastric Cancer Prevention: an Update of a Meta-analysis.Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.Meta-analysis on the association between non-steroidal anti-inflammatory drug use and ovarian cancer.Long-Term Low-Dose Aspirin Use Reduces Gastric Cancer Incidence: A Nationwide Cohort StudyPopulation-wide Impact of Long-term Use of Aspirin and the Risk for CancerNonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study
P2860
Q24602426-7A97D9F7-F827-4092-A0DC-2713D7BE237EQ26784036-04B354CD-7E9F-4DD7-ADD6-FCAB4A78B85AQ26825742-AC1F8A39-C3E5-42C0-BA1E-66D53391D7DCQ26849435-ECF309D3-1061-495E-9F42-94AC88B63472Q26849652-60CE23B3-28BC-4EEC-ABA9-C1F38110427BQ26860418-F4EF7E31-D909-46DF-AD98-D8F3E8BCE7B9Q27024919-114D9ECE-581A-40BD-856B-40CAC9149F3DQ27027061-C2F76910-7D04-4D97-A69E-EED3CA02A134Q28274081-985AB13E-1CC8-4420-9701-B1A26BAA7B6DQ30239019-CD7310F8-7410-49AF-BCFD-EA1CA7ED8E05Q30248417-00713348-3D83-4A6A-ADDC-09AA0B0DD706Q31119674-6F53E57D-83DC-416A-9703-B63576DA5331Q33347546-69BD6CC8-1DB7-4981-932A-82AAC0E196FDQ33555216-D3811B52-EB5B-4163-B82C-6D14BCBB3CC9Q33630778-DF066885-24FF-4AD3-B359-DB1E0FF4DF06Q33664095-E7F20C76-F3D1-4126-9705-8FFE6DA7FBECQ33834355-C14DA23D-8ABB-40E7-90A7-24611522C452Q33911623-80C543D9-F08C-48EE-9685-7F6534BF5F95Q33984604-3ADEE0B8-2D92-4808-9E82-43AA13E3F246Q34122764-89AAE7E2-8F9C-44FB-8EE1-61FDD8C635F4Q34194651-DF8EBF1F-F39D-41D8-A328-28269F22441DQ34294719-DAEC5098-BE38-4FDB-BD36-892DE4EA1B1FQ34898182-4AB7CF8E-9337-479B-96CA-4AC6B60E152DQ34923812-8F362A88-A223-4956-8CDB-262C671F16D4Q35046884-885BFF32-1EB8-425E-AE58-A00C29755DBDQ35057339-87E63FF0-644D-42AF-AEDD-4C982A5CB7C2Q35156722-B644AF28-B99E-4411-AC58-8CF3A8EDFF47Q35172224-9915B4BA-3DE5-426C-8190-D390362B3BF4Q35673305-FF2CA662-2CEE-4870-AD7C-E4723FE95A38Q35814510-9B20227D-0261-4F1C-AF8F-4B773A552C13Q36076749-F8272A09-E99C-40E7-BB87-40A295B07761Q36097149-2D1BC681-8715-41C6-A1EE-B3FDDCAAEA33Q36117678-65ACAE08-1C68-4BC7-A3A8-06867ADCA0A8Q36187239-FC6DB71E-136E-4590-9A7D-96D92E5C8F8DQ36229025-EEDB300D-5DDC-410A-AFA8-5715F31438ECQ36370513-629D6348-074D-4064-AC7F-3035605D375DQ36562438-0399AC61-EB02-44A5-8D8D-8B7EFD058AF3Q36832247-2E01EC12-7E9E-420C-8CCE-2F968E96164FQ36989392-9115B6C7-BF2F-45DE-8C9B-2AE05BE2881EQ37305861-DB7479C6-A048-4B8E-BA69-FFFA9BDFB46F
P2860
Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-steroidal anti-inflammator ...... ort study and a meta-analysis.
@en
Non-steroidal anti-inflammator ...... ort study and a meta-analysis.
@nl
type
label
Non-steroidal anti-inflammator ...... ort study and a meta-analysis.
@en
Non-steroidal anti-inflammator ...... ort study and a meta-analysis.
@nl
prefLabel
Non-steroidal anti-inflammator ...... ort study and a meta-analysis.
@en
Non-steroidal anti-inflammator ...... ort study and a meta-analysis.
@nl
P2093
P2860
P921
P356
P1476
Non-steroidal anti-inflammator ...... ort study and a meta-analysis.
@en
P2093
A R Hollenbeck
A Schatzkin
F Kamangar
M F Leitzmann
N D Freedman
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604880
P407
P577
2009-01-20T00:00:00Z